|
We asked 40 pharma leaders, should FDA be forced to make changes in how it regulates the drug industry?
| Strongly agree |
44% |
| Agree somewhat |
34% |
| Disagree somewhat |
11% |
| Disagree strongly |
11% |
 |
|
|
|
|
|
|
|
4 August, 2012
|
| In this Issue |
 |
Pipeline Rebound Predicted
An expected 160 to 185 new molecular entities are expected to be launched between 2012 and 2016, according to new research from IMS Health. Read more... |
EU Pins Hopes on HTA Network for Consensus on Value
The European Union's proposed health technology assessment network to encourage "cooperation and exchange of scientific information among member states" is a significant step, says Reflector. But, as far as standardizing an approach to value is concerned, will it be a damp squib? More... |
US: Medical Journals Follow Docs to the iPad
It’s something of an enigma that most physicians are keen to learn about and use cutting edge medicines and devices for their patients, but are often apathetic or worse when it comes to new communication technologies and digital information exchange. Where else can you spot a fax machine being actively used these days, outside of a hospital or doctor’s office? More... |
Can EU Countries Agree on Relative Benefit?
As governments struggle to rein in public spending in the European Union, drug pricing "is becoming increasingly intertwined with the on-going financial crisis". And the consequences are that life is likely to get harder for people designing clinical trials, according to European Healthcare Policy, a new report from the GlobalData business intelligence service. More...
|
| Recruitment Profile |
| |
Dessault Systems
Business Consultant Director
Life Sciences Director H/F
Dassault Systèmes, the 3D Experience Company, provides business and people with virtual universes to imagine sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and supported.
 Read more |
|
|
|
|
